课题基金 / 基金详情

项目摘要

项目成果

David L. Roman的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):G蛋白信号传导调节剂(RGS)蛋白是通过G蛋白偶联受体(GPCR)启动的信号的重要调节剂。RGS蛋白的作用是通过调节G蛋白信号加速G蛋白信号的失活。亚基GTPase活性,导致信号终止。虽然GPCR是经典的药物靶标,但许多细胞过程可以通过改变RGS蛋白的作用来调节。我建议测量的相互作用亲和力的各种RGS蛋白的效应蛋白(即G?)使用新的高通量流式细胞术方法。在建立这些参数的情况下,将使用高通量流式细胞术方法筛选不同化合物(约35,000种)的文库以鉴定RGS活性的调节剂。一旦确定了调节剂,将评估完整的定量结构-活性关系,并在生物化学和基于细胞的测定中表征其他类似化合物。这些药理学调节剂的使用将为研究RGS蛋白可发挥作用的各种疾病提供效用,包括帕金森病(RGS 9)、精神分裂症(RGS 4)以及细胞增殖和转移(LARG)。
英文摘要
DESCRIPTION (provided by applicant): Regulators of G-protein signaling (RGS) proteins are important modulators of signals initiated through G- protein coupled receptors (GPCRs). The action of RGS proteins is the acceleration of the deactivation of G- protein signals through modulation of G? subunit GTPase activity, which causes a termination of signal. While GPCRs have been classical drug targets, many cellular processes can be modulated by altering the action of RGS proteins. I propose to measure the interaction affinity of a variety of RGS proteins for their effector proteins (i.e. G?) using a novel high throughput flow cytometric method. With these parameters established, a library of diverse chemical compounds (~35,000) will be screened to identify modulators of RGS activity using the high throughput flow cytometric method. Once modulators are identified, complete quantitative structure-activity relationships will be evaluated and additional similar compounds will be characterized in both biochemical and cell-based assays. The use of these pharmacological modulators would provide utility for studying various disease in which RGS proteins could play a role, including Parkinson's disease (RGS9), Schizophrenia (RGS4), as well as cell proliferation and metastasis (LARG).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predoctoral Training in the Pharmacological Sciences
  • 批准号:
    10347969
  • 项目类别:
  • 资助金额:
    $38.82万
  • 财政年份:
    2022
  • 负责人:
    David L. Roman
  • 依托单位:
Predoctoral Training in the Pharmacological Sciences
  • 批准号:
    10621722
  • 项目类别:
  • 资助金额:
    $39.73万
  • 财政年份:
    2022
  • 负责人:
    David L. Roman
  • 依托单位:
Non-opioids for inflammatory pain: Adenylyl cyclase 1 as a novel target
  • 批准号:
    10397712
  • 项目类别:
  • 资助金额:
    $35.32万
  • 财政年份:
    2021
  • 负责人:
    David L. Roman
  • 依托单位:
Non-Opioids for Inflammatory Pain: Adenylyl Cyclase 1 as a Novel Target
  • 批准号:
    10525509
  • 项目类别:
  • 资助金额:
    $6.01万
  • 财政年份:
    2021
  • 负责人:
    David L. Roman
  • 依托单位:
国内基金
海外基金
抗禾谷镰刀菌3-Decalinoyltetramic Acids类天然产物的挖掘及基于“靶标垂钓”策略的作用机制研究
真菌中同一PKS-NRPS基因簇合成两种不同骨架tetramic acids机制研究
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
  • 批准号:
    22007039
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王黎明
  • 依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究